2026 Q3 Portfolio Activity
In 2026 Q3, PFIZER INC maintained a portfolio of 17 distinct positions. They heavily accumulated shares in AGOMAB THERAPEUTICS NV, increasing the position by 2768.3%.
Position History
hover any row below to update
Loading…
PFIZER INC
New York, NY
Public Company (Corporate Treasury / Institutional Investment Manager)
AUM $164M
Total Positions
17
Quarter
2026 Q3
Top Holding
ALLO (22.1%)
Top 10 Concentration
95.1%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-17 of 17
PFIZER INC Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ALLO
ALLOGENE THERAP...
|
Healthcare | 22.13% | 27.55% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
22,032,040 | $36,352,866 |
$2.13
-60.6%
|
2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | ||
|
ARVN
ARVINAS INC
|
Healthcare | 15.98% | 16.24% |
#2
1
Prev: #3
|
6.5 |
—
|
no change | no change |
P
S
|
3,457,815 | $26,244,816 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
CELC
CELCUITY INC
|
Healthcare | 14.31% | 17.35% |
#3
1
Prev: #2
|
6.0 |
—
|
no change | no change |
P
S
|
295,652 | $23,510,247 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
AGMB
AGOMAB THERAPEU...
|
Healthcare | 13.77% | 0.61% |
#4
9
Prev: #13
|
7.5 |
—
|
2,076,213 | 2768.3% |
P
S
|
2,151,213 | $22,609,249 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
PYXS
PYXIS ONCOLOGY ...
|
Healthcare | 12.25% | 11.43% |
#5
1
Prev: #4
|
5.5 |
—
|
no change | no change |
P
S
|
7,032,770 | $20,113,722 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
WVE
WAVE LIFE SCIEN...
|
Healthcare | 4.32% | 6.42% |
#6
1
Prev: #5
|
2.7 |
—
|
no change | no change |
P
S
|
1,875,000 | $7,087,500 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
BHVN
BIOHAVEN LTD
|
Healthcare | 4.00% | 4.70% |
#7
1
Prev: #6
|
2.6 |
—
|
no change | no change |
P
S
|
505,645 | $6,568,329 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
CRBU
CARIBOU BIOSCIE...
|
Healthcare | 3.54% | 4.63% |
#8
1
Prev: #7
|
2.4 |
—
|
no change | no change |
P
S
|
4,690,431 | $5,816,134 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
ORIC
ORIC PHARMACEUT...
|
Healthcare | 2.99% | 2.09% |
#9
1
Prev: #10
|
2.2 |
—
|
no change | no change |
P
S
|
372,904 | $4,907,417 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
CRDF
CARDIFF ONCOLOG...
|
Healthcare | 1.82% | 1.77% |
#10
1
Prev: #11
|
1.7 |
—
|
no change | no change |
P
S
|
2,411,575 | $2,990,353 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
SPRO
SPERO THERAPEUT...
|
Healthcare | 1.77% | 3.13% |
#11
3
Prev: #8
|
1.7 |
—
|
no change | no change |
P
S
|
2,362,348 | $2,905,688 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
ZNTL
ZENTALIS PHARMA...
|
Healthcare | 1.57% | 2.26% |
#12
3
Prev: #9
|
1.6 |
—
|
no change | no change |
P
S
|
953,834 | $2,575,352 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
ZURA
ZURA BIO LTD
|
Healthcare | 1.33% | 1.69% |
#13
1
Prev: #12
|
1.5 |
—
|
no change | no change |
P
S
|
538,841 | $2,176,918 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
NXTC
NEXTCURE INC
|
Healthcare | 0.14% | 0.04% |
#14
1
Prev: #15
|
0.6 |
—
|
10 | 0.0% |
P
S
|
44,357 | $225,334 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
BOLT
BOLT BIOTHERAPE...
|
Healthcare | 0.07% | 0.08% |
#15
1
Prev: #14
|
1.0 |
—
|
no change | no change |
P
S
|
31,305 | $112,072 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
DNA
GINKGO BIOWORKS...
|
Healthcare | 0.02% | 0.02% |
#16
Prev: #16
|
1.0 |
—
|
no change | no change |
P
S
|
2,928 | $31,213 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 | |||
|
SENS
SENSEONICS HLDG...
|
Healthcare | 0.01% | 0.01% |
#17
Prev: #17
|
1.0 |
—
|
no change | no change |
P
S
|
2,171 | $21,710 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-12 |
Showing 1-17 of 17 holdings